PA Rheumatology Society is bringing the 3rd year of Cross Border Summer Series in collaboration with Marisa Mizus from Maryland Society for the Rheumatic Diseases!
It’s free and has three great talks lined up for your Summer education. Sign up below!
@PaRheum
🌍 Ready to shape the future of lupus care?
Join us in Toronto for #LUPUS2025 and enjoy the Early Rate – available only until 4 February 4! Don’t miss your chance to save and be part of this global congress.
🦋 Register now: https://t.co/LL39XH1nHt
#Rheum#Rheumatology#Lupus
It was wonderful working with the @LupusInitiative’s COIN Committee this year on the updated Virtual Lupus Provider Series and even more wonderful to meet all the forces behind this project in person !
@ACRheum
🌎 #ACR24#ACRambassador
🗓️Wonderful Year in Review!
🌟 Nav 1.7 ▶️ future target for #OA
🌟 Netrin-4 ▶️Answer to your #RA pain?
🌟 #JAKinib ▶️Entering new frontiers in #TEN T/t
🌟 #Xist ▶️ When proteins turn out to be biased!
🌟 Mimicry in MIS-C
🌟 Dont miss the summary! ⬇️
1/2
Thank you @ACRheum for giving me and @AHNRheum the opportunity to present our work on HCQ retinal screening in lupus.
🌟our study shows low levels of adherence to the eye exam recommendations at baseline and after 5 years
#ACR24@Lupusreference thanks for stopping by!
❓hsCRP or LDL? Better CV risk marker?🤔
🌟Wonderful session on CV risk and role of #Colchicine
🌟Data says:
✅ ⬆️hsCRP has more CV risk than LDL
✅ If hsCRP <2 mg/L, risk same even if LDL >70 mg/dL
Also,
❓Are you using Colchicine enough in your practice?
#ACR24#ACRambassador
Myths by Daniel Clauw
Small fiber neuropathy - misnomer, non-specific, not worth getting a skin biopsy
Fibromyalgia is not autoimmune - it is nociplastic pain and treated differently
#ACR24 Review Course
@RheumNow
🌟Practical tips by Dr. Okoye to identify active rash in pts with skin of color
I personally love the tip of using a blue background or taking a photograph to highlight erythema which may be difficult to appreciate otherwise
#ACR24@ACRheum
🌟Plenary at #ACR24 by @DrPeterMerkel - Upa in GCA
Potential new targeted therapy in GCA
🌟Upa 15mg daily superior to placebo
🌟allows for rapid GC taper
🌟AEs with no MACE events
#ACRambassador@ACRheum
48 hours until #ACR2024 begins in Washington, D.C.!
Our Preview Podcast is LIVE! Tune in to hear Professors Ed Vital and Cynthia Aranow as they break down the must-attend events of the congress.
👉 Listen now: https://t.co/MpvrEABAEx
Getting ready to present our work on adherence to retinal toxicity monitoring in #lupus patients on #Hydroxychloroquine at #ACR24
Looking forward to seeing friends and colleagues in Washington DC!